NCT04945603 Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
| NCT ID | NCT04945603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Subarachnoid Hemorrhage, Aneurysmal |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2021-05-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2021-05-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicentric registry study in order to define outcome, predictors, treatment effects and their modifiers in poor grade aneurysmal subarachnoid haemorrhage patients. The search for outcome predictors is going to be subdivided into three main research areas: 1. outcome predictors in the emergency department (so called "early brain injury phase"). 2. outcome predictors in the neurocritical care unit (so called "delayed brain injury phase"). 3. Treatment strategies. Two other areas of research are identified: delayed cerebral ischemia (incidence, treatment, predictors, impact on outcome) and long term follow-up (recent evidences suggest that there may be a non-negligible proportion of poor grade subarachnoid hemorrhage patients who may benefit from substantial improvement at long-term (after 6-12 months of follow-up).
Eligibility Criteria
Inclusion Criteria: * Patients admitted to the emergency department because of aneurysmal subarachnoid hemorrhage of poor grade (IV-V) according to the WFNS classification. Exclusion Criteria: * Patients younger than 18 years old. * Pregnant or breast-feeding patients. * Aneurysmal subarachnoid hemorrhage due to trauma or vascular malformations other than cerebral aneurysms.
Contact & Investigator
Pietro Panni, P.I., M.D.
PRINCIPAL INVESTIGATOR
Department of Neuroradiology, Department of Neurosurgery
Frequently Asked Questions
Who can join the NCT04945603 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Subarachnoid Hemorrhage, Aneurysmal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04945603 currently recruiting?
Yes, NCT04945603 is actively recruiting participants. Contact the research team at panni.pietro@hsr.it for enrollment information.
Where is the NCT04945603 trial being conducted?
This trial is being conducted at Bergamo, Italy, Bologna, Italy, Brescia, Italy, Lecce, Italy and 6 additional locations.
Who is sponsoring the NCT04945603 clinical trial?
NCT04945603 is sponsored by IRCCS San Raffaele. The principal investigator is Pietro Panni, P.I., M.D. at Department of Neuroradiology, Department of Neurosurgery. The trial plans to enroll 800 participants.